位置:首页 > 蛋白库 > SRTA_STAA8
SRTA_STAA8
ID   SRTA_STAA8              Reviewed;         206 AA.
AC   Q2FV99;
DT   10-OCT-2018, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   03-AUG-2022, entry version 85.
DE   RecName: Full=Sortase A {ECO:0000305};
DE            EC=3.4.22.70 {ECO:0000269|PubMed:10535938, ECO:0000269|PubMed:11371637, ECO:0000269|PubMed:14503881, ECO:0000269|PubMed:14769030, ECO:0000269|PubMed:15247224, ECO:0000269|PubMed:16269411, ECO:0000269|PubMed:17518446};
DE   AltName: Full=Surface protein sorting A {ECO:0000303|PubMed:10427003};
GN   Name=srtA {ECO:0000303|PubMed:10427003};
GN   OrderedLocusNames=SAOUHSC_02834 {ECO:0000312|EMBL:ABD31836.1};
OS   Staphylococcus aureus (strain NCTC 8325 / PS 47).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325 / PS 47;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W., Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC 8325 genome.";
RL   (In) Fischetti V., Novick R., Ferretti J., Portnoy D., Rood J. (eds.);
RL   Gram positive pathogens, 2nd edition, pp.381-412, ASM Press, Washington
RL   D.C. (2006).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10427003; DOI=10.1126/science.285.5428.760;
RA   Mazmanian S.K., Liu G., Ton-That H., Schneewind O.;
RT   "Staphylococcus aureus sortase, an enzyme that anchors surface proteins to
RT   the cell wall.";
RL   Science 285:760-763(1999).
RN   [3]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=10446208; DOI=10.1074/jbc.274.34.24316;
RA   Ton-That H., Schneewind O.;
RT   "Anchor structure of staphylococcal surface proteins. IV. Inhibitors of the
RT   cell wall sorting reaction.";
RL   J. Biol. Chem. 274:24316-24320(1999).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND MUTAGENESIS OF
RP   CYS-184.
RC   STRAIN=BB270, and RN4220 / OS2;
RX   PubMed=10535938; DOI=10.1073/pnas.96.22.12424;
RA   Ton-That H., Liu G., Mazmanian S.K., Faull K.F., Schneewind O.;
RT   "Purification and characterization of sortase, the transpeptidase that
RT   cleaves surface proteins of Staphylococcus aureus at the LPXTG motif.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:12424-12429(1999).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10805806; DOI=10.1073/pnas.080520697;
RA   Mazmanian S.K., Liu G., Jensen E.R., Lenoy E., Schneewind O.;
RT   "Staphylococcus aureus sortase mutants defective in the display of surface
RT   proteins and in the pathogenesis of animal infections.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5510-5515(2000).
RN   [6]
RP   FUNCTION, MUTAGENESIS OF HIS-120; CYS-184 AND TRP-194, AND ACTIVE SITE.
RX   PubMed=11714722; DOI=10.1074/jbc.m109945200;
RA   Ton-That H., Mazmanian S.K., Alksne L., Schneewind O.;
RT   "Anchoring of surface proteins to the cell wall of Staphylococcus aureus.
RT   Cysteine 184 and histidine 120 of sortase form a thiolate-imidazolium ion
RT   pair for catalysis.";
RL   J. Biol. Chem. 277:7447-7452(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=11856734; DOI=10.1074/jbc.m109194200;
RA   Perry A.M., Ton-That H., Mazmanian S.K., Schneewind O.;
RT   "Anchoring of surface proteins to the cell wall of Staphylococcus aureus.
RT   III. Lipid II is an in vivo peptidoglycan substrate for sortase-catalyzed
RT   surface protein anchoring.";
RL   J. Biol. Chem. 277:16241-16248(2002).
RN   [8]
RP   CATALYTIC ACTIVITY.
RX   PubMed=14503881; DOI=10.1021/bi034391g;
RA   Huang X., Aulabaugh A., Ding W., Kapoor B., Alksne L., Tabei K.,
RA   Ellestad G.;
RT   "Kinetic mechanism of Staphylococcus aureus sortase SrtA.";
RL   Biochemistry 42:11307-11315(2003).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOTECHNOLOGY.
RX   PubMed=14769030; DOI=10.1021/bi035920j;
RA   Kruger R.G., Otvos B., Frankel B.A., Bentley M., Dostal P.,
RA   McCafferty D.G.;
RT   "Analysis of the substrate specificity of the Staphylococcus aureus sortase
RT   transpeptidase SrtA.";
RL   Biochemistry 43:1541-1551(2004).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF ASN-98; CYS-184 AND ARG-197,
RP   AND ACTIVE SITE.
RX   PubMed=15247224; DOI=10.1074/jbc.m405282200;
RA   Marraffini L.A., Ton-That H., Zong Y., Narayana S.V., Schneewind O.;
RT   "Anchoring of surface proteins to the cell wall of Staphylococcus aureus. A
RT   conserved arginine residue is required for efficient catalysis of sortase
RT   A.";
RL   J. Biol. Chem. 279:37763-37770(2004).
RN   [11]
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, CALCIUM-BINDING, AND MUTAGENESIS
RP   OF GLU-108; ASP-170 AND GLU-171.
RX   PubMed=16269411; DOI=10.1074/jbc.m506123200;
RA   Naik M.T., Suree N., Ilangovan U., Liew C.K., Thieu W., Campbell D.O.,
RA   Clemens J.J., Jung M.E., Clubb R.T.;
RT   "Staphylococcus aureus sortase A transpeptidase. Calcium promotes sorting
RT   signal binding by altering the mobility and structure of an active site
RT   loop.";
RL   J. Biol. Chem. 281:1817-1826(2006).
RN   [12]
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF HIS-120; THR-180; LEU-181; ILE-182;
RP   THR-183; CYS-184; ASP-185; ASP-186 AND ARG-197, AND ACTIVE SITE.
RX   PubMed=17518446; DOI=10.1021/bi700448e;
RA   Frankel B.A., Tong Y., Bentley M.L., Fitzgerald M.C., McCafferty D.G.;
RT   "Mutational analysis of active site residues in the Staphylococcus aureus
RT   transpeptidase SrtA.";
RL   Biochemistry 46:7269-7278(2007).
RN   [13]
RP   SUBUNIT.
RX   PubMed=17658894; DOI=10.1021/bi700519w;
RA   Lu C., Zhu J., Wang Y., Umeda A., Cowmeadow R.B., Lai E., Moreno G.N.,
RA   Person M.D., Zhang Z.;
RT   "Staphylococcus aureus sortase A exists as a dimeric protein in vitro.";
RL   Biochemistry 46:9346-9354(2007).
RN   [14]
RP   ACTIVITY REGULATION, SUBUNIT, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND MUTAGENESIS OF ASN-132; LYS-137 AND TYR-143.
RC   STRAIN=RN4220;
RX   PubMed=26129884; DOI=10.1177/1535370215592122;
RA   Zhu J., Xiang L., Jiang F., Zhang Z.J.;
RT   "Equilibrium of sortase A dimerization on Staphylococcus aureus cell
RT   surface mediates its cell wall sorting activity.";
RL   Exp. Biol. Med. (Maywood) 241:90-100(2016).
RN   [15] {ECO:0007744|PDB:1IJA}
RP   STRUCTURE BY NMR OF 59-206, CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   SUBCELLULAR LOCATION, AND ACTIVE SITE.
RC   STRAIN=RN4220 / OS2;
RX   PubMed=11371637; DOI=10.1073/pnas.101064198;
RA   Ilangovan U., Ton-That H., Iwahara J., Schneewind O., Clubb R.T.;
RT   "Structure of sortase, the transpeptidase that anchors proteins to the cell
RT   wall of Staphylococcus aureus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:6056-6061(2001).
RN   [16] {ECO:0007744|PDB:1T2O, ECO:0007744|PDB:1T2P, ECO:0007744|PDB:1T2W}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 62-206 OF WILD-TYPE; MUTANT
RP   ALA-184 AND MUTANT ALA-184 IN COMPLEX WITH A LPETG PEPTIDE, AND ACTIVE
RP   SITE.
RX   PubMed=15117963; DOI=10.1074/jbc.m401374200;
RA   Zong Y., Bice T.W., Ton-That H., Schneewind O., Narayana S.V.;
RT   "Crystal structures of Staphylococcus aureus sortase A and its substrate
RT   complex.";
RL   J. Biol. Chem. 279:31383-31389(2004).
RN   [17] {ECO:0007744|PDB:2KID}
RP   STRUCTURE BY NMR OF 59-206 IN COMPLEX WITH SUBSTRATE ANALOG AND CALCIUM,
RP   AND MUTAGENESIS OF LEU-97; ALA-104 AND ALA-118.
RX   PubMed=19592495; DOI=10.1074/jbc.m109.022624;
RA   Suree N., Liew C.K., Villareal V.A., Thieu W., Fadeev E.A., Clemens J.J.,
RA   Jung M.E., Clubb R.T.;
RT   "The structure of the Staphylococcus aureus sortase-substrate complex
RT   reveals how the universally conserved LPXTG sorting signal is recognized.";
RL   J. Biol. Chem. 284:24465-24477(2009).
CC   -!- FUNCTION: Transpeptidase that anchors surface proteins to the cell wall
CC       (PubMed:10427003, PubMed:10446208, PubMed:10535938, PubMed:11714722,
CC       PubMed:14769030, PubMed:15247224). Recognizes and modifies its
CC       substrate by proteolytic cleavage of a C-terminal sorting signal.
CC       Following cleavage, a covalent intermediate is formed via a thioester
CC       bond between the sortase and its substrate, which is then transferred
CC       and covalently attached to the cell wall (PubMed:10446208,
CC       PubMed:10535938, PubMed:11714722, PubMed:14769030, PubMed:15247224).
CC       This sortase recognizes a Leu-Pro-x-Thr-Gly (LPXTG) motif, which is
CC       cleaved by the sortase between the threonine and glycine residues
CC       (PubMed:10535938, PubMed:11714722, PubMed:14769030, PubMed:15247224).
CC       Utilizes lipid II as the peptidoglycan substrate for the sorting
CC       reaction (PubMed:10446208, PubMed:11856734). Responsible for the
CC       display of important virulence factors (PubMed:14769030). Important for
CC       interactions with the host and host colonization during infection
CC       (PubMed:10805806, PubMed:14769030). {ECO:0000269|PubMed:10427003,
CC       ECO:0000269|PubMed:10446208, ECO:0000269|PubMed:10535938,
CC       ECO:0000269|PubMed:10805806, ECO:0000269|PubMed:11714722,
CC       ECO:0000269|PubMed:11856734, ECO:0000269|PubMed:14769030,
CC       ECO:0000269|PubMed:15247224}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=The enzyme catalyzes a cell wall sorting reaction in which a
CC         surface protein with a sorting signal containing a LPXTG motif is
CC         cleaved between the Thr and Gly residue. The resulting threonine
CC         carboxyl end of the protein is covalently attached to a pentaglycine
CC         cross-bridge of peptidoglycan.; EC=3.4.22.70;
CC         Evidence={ECO:0000269|PubMed:10535938, ECO:0000269|PubMed:11371637,
CC         ECO:0000269|PubMed:14503881, ECO:0000269|PubMed:14769030,
CC         ECO:0000269|PubMed:15247224, ECO:0000269|PubMed:16269411,
CC         ECO:0000269|PubMed:17518446};
CC   -!- ACTIVITY REGULATION: Sortase activity is regulated by monomer-homodimer
CC       equilibrium. Mutant cells with monomeric SrtA display more adhesive
CC       proteins on the cell surface and are more invasive than wild-type
CC       cells, which have majority of SrtA in dimeric form. Dimerization may
CC       suppress the enzymatic activity on cell membranes (PubMed:26129884).
CC       Stimulated by calcium ions, which promote substrate binding
CC       (PubMed:11371637, PubMed:16269411). Calcium ions bind to SrtA and
CC       modulate both the structure and dynamics of a large active site loop
CC       (PubMed:16269411). Can also be stimulated, to a lesser extent, by
CC       Mg(2+) and Mn(2+) (PubMed:11371637). Inhibited by sulfhydryl-modifying
CC       reagents (PubMed:10535938, PubMed:10446208).
CC       {ECO:0000269|PubMed:10446208, ECO:0000269|PubMed:10535938,
CC       ECO:0000269|PubMed:11371637, ECO:0000269|PubMed:16269411,
CC       ECO:0000269|PubMed:26129884}.
CC   -!- SUBUNIT: Monomer and homodimer; in equilibrium.
CC       {ECO:0000269|PubMed:17658894, ECO:0000269|PubMed:26129884}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26129884,
CC       ECO:0000305|PubMed:11371637}; Single-pass type II membrane protein
CC       {ECO:0000305|PubMed:11371637}.
CC   -!- DISRUPTION PHENOTYPE: Mutants fail to cleave and anchor surface
CC       proteins (PubMed:10427003, PubMed:10805806). Protein secretion pathway
CC       is not affected (PubMed:10805806). Mutants are defective in the
CC       establishment of animal infections (PubMed:10805806).
CC       {ECO:0000269|PubMed:10427003, ECO:0000269|PubMed:10805806}.
CC   -!- BIOTECHNOLOGY: Could be used as a target for the development of
CC       antivirulence chemotherapeutics against Gram-positive bacterial
CC       pathogens. {ECO:0000305|PubMed:14769030}.
CC   -!- SIMILARITY: Belongs to the bacterial sortase family. Class A subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000253; ABD31836.1; -; Genomic_DNA.
DR   RefSeq; WP_000759361.1; NZ_LS483365.1.
DR   RefSeq; YP_501293.1; NC_007795.1.
DR   PDB; 1IJA; NMR; -; A=59-206.
DR   PDB; 1T2O; X-ray; 2.30 A; A/B/C=61-206.
DR   PDB; 1T2P; X-ray; 2.00 A; A/B/C=61-206.
DR   PDB; 1T2W; X-ray; 1.80 A; A/B/C=62-206.
DR   PDB; 2KID; NMR; -; A=59-206.
DR   PDB; 6R1V; NMR; -; A=59-206.
DR   PDB; 7S54; X-ray; 1.79 A; A/B=185-199.
DR   PDBsum; 1IJA; -.
DR   PDBsum; 1T2O; -.
DR   PDBsum; 1T2P; -.
DR   PDBsum; 1T2W; -.
DR   PDBsum; 2KID; -.
DR   PDBsum; 6R1V; -.
DR   PDBsum; 7S54; -.
DR   AlphaFoldDB; Q2FV99; -.
DR   BMRB; Q2FV99; -.
DR   SMR; Q2FV99; -.
DR   STRING; 1280.SAXN108_2777; -.
DR   MEROPS; C60.001; -.
DR   EnsemblBacteria; ABD31836; ABD31836; SAOUHSC_02834.
DR   GeneID; 3921273; -.
DR   KEGG; sao:SAOUHSC_02834; -.
DR   PATRIC; fig|93061.5.peg.2564; -.
DR   eggNOG; COG3764; Bacteria.
DR   HOGENOM; CLU_1405331_0_0_9; -.
DR   OMA; MRADQKM; -.
DR   Proteomes; UP000008816; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd06165; Sortase_A; 1.
DR   Gene3D; 2.40.260.10; -; 1.
DR   InterPro; IPR005754; Sortase.
DR   InterPro; IPR042007; Sortase_A.
DR   InterPro; IPR023365; Sortase_dom-sf.
DR   Pfam; PF04203; Sortase; 1.
DR   SUPFAM; SSF63817; SSF63817; 1.
DR   TIGRFAMs; TIGR01076; sortase_fam; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Hydrolase; Membrane; Metal-binding; Protease;
KW   Reference proteome; Thiol protease; Transmembrane; Transmembrane helix.
FT   CHAIN           1..206
FT                   /note="Sortase A"
FT                   /id="PRO_0000445268"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:11371637"
FT   TRANSMEM        7..24
FT                   /note="Helical; Note=Membrane anchor"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:11371637"
FT   TOPO_DOM        25..206
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:11371637"
FT   REGION          49..69
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..65
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        120
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000305|PubMed:11371637,
FT                   ECO:0000305|PubMed:11714722, ECO:0000305|PubMed:15117963,
FT                   ECO:0000305|PubMed:15247224, ECO:0000305|PubMed:17518446"
FT   ACT_SITE        184
FT                   /note="Acyl-thioester intermediate"
FT                   /evidence="ECO:0000305|PubMed:11371637,
FT                   ECO:0000305|PubMed:11714722, ECO:0000305|PubMed:15117963,
FT                   ECO:0000305|PubMed:15247224, ECO:0000305|PubMed:17518446"
FT   BINDING         105
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:19592495,
FT                   ECO:0000305|PubMed:16269411"
FT   BINDING         108
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:19592495,
FT                   ECO:0000305|PubMed:16269411"
FT   BINDING         112
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:19592495,
FT                   ECO:0000305|PubMed:16269411"
FT   BINDING         114
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:19592495,
FT                   ECO:0000305|PubMed:16269411"
FT   BINDING         171
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:19592495,
FT                   ECO:0000305|PubMed:16269411"
FT   SITE            197
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000305|PubMed:15117963,
FT                   ECO:0000305|PubMed:15247224, ECO:0000305|PubMed:17518446"
FT   MUTAGEN         97
FT                   /note="L->A: Decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:19592495"
FT   MUTAGEN         98
FT                   /note="N->A,Q: No change in sortase activity."
FT                   /evidence="ECO:0000269|PubMed:15247224"
FT   MUTAGEN         104
FT                   /note="A->G: Decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:19592495"
FT   MUTAGEN         108
FT                   /note="E->A: Retains enzymatic activity. Shows reduced
FT                   Ca(2+) sensitivity."
FT                   /evidence="ECO:0000269|PubMed:16269411"
FT   MUTAGEN         118
FT                   /note="A->G: Decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:19592495"
FT   MUTAGEN         120
FT                   /note="H->A: Almost loss or loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11714722,
FT                   ECO:0000269|PubMed:17518446"
FT   MUTAGEN         120
FT                   /note="H->Q: Almost loss of activity."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         132
FT                   /note="N->A: Does not affect dimerization of the full-
FT                   length protein. Disrupts dimerization; when associated with
FT                   A-137 and A-143."
FT                   /evidence="ECO:0000269|PubMed:26129884"
FT   MUTAGEN         137
FT                   /note="K->A: Does not affect dimerization of the full-
FT                   length protein. Disrupts dimerization; when associated with
FT                   A-132 and A-143."
FT                   /evidence="ECO:0000269|PubMed:26129884"
FT   MUTAGEN         143
FT                   /note="Y->A: Does not affect dimerization of the full-
FT                   length protein. Disrupts dimerization; when associated with
FT                   A-132 and A-137."
FT                   /evidence="ECO:0000269|PubMed:26129884"
FT   MUTAGEN         170
FT                   /note="D->A: Retains enzymatic activity. No change in
FT                   dependence on Ca(2+)."
FT                   /evidence="ECO:0000269|PubMed:16269411"
FT   MUTAGEN         171
FT                   /note="E->A: Retains enzymatic activity. Shows reduced
FT                   Ca(2+) sensitivity."
FT                   /evidence="ECO:0000269|PubMed:16269411"
FT   MUTAGEN         180
FT                   /note="T->A: Decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         181
FT                   /note="L->A: Decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         182
FT                   /note="I->A,S: Decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         183
FT                   /note="T->A: Strong decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         184
FT                   /note="C->A: Abolishes sortase activity."
FT                   /evidence="ECO:0000269|PubMed:10535938,
FT                   ECO:0000269|PubMed:11714722, ECO:0000269|PubMed:17518446"
FT   MUTAGEN         184
FT                   /note="C->H: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         184
FT                   /note="C->R: Abolishes sortase processing; when associated
FT                   with C-197."
FT                   /evidence="ECO:0000269|PubMed:15247224"
FT   MUTAGEN         184
FT                   /note="C->S: Retains low levels of activity."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         185
FT                   /note="D->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         186
FT                   /note="D->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:17518446"
FT   MUTAGEN         194
FT                   /note="W->A: Decreases the transpeptidase activity."
FT                   /evidence="ECO:0000269|PubMed:11714722"
FT   MUTAGEN         197
FT                   /note="R->A,K: Strong decrease in catalytic efficiency.
FT                   Does not affect substrate cleavage specificity. Severe
FT                   decrease in sortase transpeptidase activity."
FT                   /evidence="ECO:0000269|PubMed:15247224,
FT                   ECO:0000269|PubMed:17518446"
FT   MUTAGEN         197
FT                   /note="R->C: Abolishes sortase processing; when associated
FT                   with R-184."
FT                   /evidence="ECO:0000269|PubMed:15247224"
FT   MUTAGEN         197
FT                   /note="R->H: Does not affect substrate cleavage
FT                   specificity. Severe decrease in sortase transpeptidase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15247224"
FT   STRAND          69..71
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          73..78
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   HELIX           79..81
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          83..88
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   HELIX           94..99
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          100..104
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          112..120
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          126..129
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          142..146
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          149..161
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          167..170
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          174..187
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   TURN            189..191
FT                   /evidence="ECO:0007829|PDB:6R1V"
FT   STRAND          194..204
FT                   /evidence="ECO:0007829|PDB:6R1V"
SQ   SEQUENCE   206 AA;  23541 MW;  DC3E65C51E145C7B CRC64;
     MKKWTNRLMT IAGVVLILVA AYLFAKPHID NYLHDKDKDE KIEQYDKNVK EQASKDKKQQ
     AKPQIPKDKS KVAGYIEIPD ADIKEPVYPG PATPEQLNRG VSFAEENESL DDQNISIAGH
     TFIDRPNYQF TNLKAAKKGS MVYFKVGNET RKYKMTSIRD VKPTDVGVLD EQKGKDKQLT
     LITCDDYNEK TGVWEKRKIF VATEVK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024